Immediate test results and patient treatment reduces the likelihood of a readmission “within 30 days of discharge” that could result in hospital penalties under Accountable Care.
“Consolidates and replaces a suitcase full of readers with a single device, that adapts to existing and FDA Cleared Point of Care tests, eliminates transportation of patient samples to central labs by testing the patient wherever they are, and transmits test results directly to The Cloud. The device that finally makes Point of Care diagnostics practical for healthcare providers."
SAN DIEGO, CA – May 3, 2022 – iAssay® Inc., a privately held developer of the world’s first open platform, point of care (POC) reader and data management system for remote medical diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has granted patent number 11,320,418. The patent includes nineteen claims, key […]
San Diego – April 10, 2022 – The recent HIMSS22 exhibition in Orlando, Florida was a resounding success for iAssay. Over the course of the event: • iAssay performed more than 25 perfect demos for booth visitors. • Numerous potential partners in the Health IT, pharmaceutical, and financial sectors were identified. • Multiple media editors […]
iAssay is thrilled to be included in Medical Product Outsourcing Magazine’s “Point-of-Care Diagnostics on Display at HIMSS 2022” article. Learn more about iAssay’s unique patent protected approach to the Cloud-connected interoperable point of care diagnostics that makes us stand out. Please reach out to info@iAssay.net to setup a call and learn more. #HIMSS22 #reimaginehealth #pointofcare
We are excited to have been noticed by a very respected publisher on life science topics: 360Dx! We were interviewed at our booth at HIMSS22, and were surprised to see this great article about iAssay appear Thursday night. See the full article here For more information, and to inquire about investments in iAssay, contact Lonnie […]
For Release March 23, 2022 FIND, the Global Alliance for Diagnostics and the iAssay Team Up to Develop Diagnostics San Diego — March 23, 2022 — Buruli ulcer is a severely debilitating disease, which starts as an inconspicuous papule and degenerates in large open wounds if left untreated. The causative pathogen is Mycobacterium ulcerans. Treatments […]
iAssay is honored to be included in Healthcare IT Today’s “HIMSS 2022 Announcements and Solutions” article. Learn more about what makes us stand out here: https://bit.ly/34sJUu0 and if you will be at HIMSS 2022 please connect with us from March 15-17 at Booth # 8140-22 in the Innovation Live Pavilion on the HIMSS22 exhibit floor! […]
For Release March 2, 2022 iAssay® Continues to Innovate and Take Interoperability in Healthcare to New Heights San Diego— March 2, 2022— iAssay has developed devices for the healthcare industry that already exceed the capabilities of currently available diagnostic readers. In addition, incorporating seamless connectivity to secure data servers ensures that data collected will conform […]
iAssay, Inc. joins MetroConnect to accelerate international growth Export assistance program to support iAssay, Inc. with growth in European and Asian medical diagnostics markets San Diego – Today, iAssay, Inc. has been named as one of 15 San Diego companies participating in MetroConnect, World Trade Center San Diego (WTCSD)’s comprehensive export assistance program that helps […]